人工心肺装置市場：製品、用途、エンドユーザー別-2025～2030年の世界予測

人工心肺装置市場は、2023年に3億691万米ドルと評価され、2024年には3億1,992万米ドルに達すると予測され、CAGR 4.38%で成長し、2030年には4億1,451万米ドルになると予測されています。

心肺バイパス（CPB）機器は心臓手術において重要であり、心肺機能のサポートが必要な手術中の血液循環と酸素供給を促進します。この機器は、冠動脈バイパス移植、心臓弁修復、心臓移植などの手術に不可欠です。生活習慣や高齢化により心血管疾患の世界的有病率が上昇する中、CPB装置の需要は増加の一途をたどっています。病院、心臓専門施設、外来手術センターがこの市場の主要な最終使用部門を形成しています。主要成長促進要因としては、低侵襲手術などの技術の発展、患者の安全性の向上、発展途上地域における医療施設の増加などが挙げられます。しかし、機器コストの高さ、規制要件の厳しさ、熟練オペレーターの必要性などの要因により、市場拡大は制約されています。革新的な研究開発を通じてこれらの課題に対処することで、新たな道が開ける可能性があります。例えば、精度を高めて人的ミスを減らすための自動化システムやAI統合システムの探求、新興国市場に適したコスト効率の高いモデルの開発などが挙げられます。さらに、遠隔医療や遠隔医療ソリューションの出現により、CPBのデータをより広範な患者管理システムに統合し、術後ケアを強化する可能性もあります。また、先進的機器の使用法に関する技術者や外科医の研修プログラムを通じて顧客サービスを強化し、最適なサービス提供を確保する機会も存在します。しかし、既存企業が市場を独占しているため競争は依然厳しく、新規参入企業にとっては参入障壁となっています。企業は継続的な製品革新、市場浸透のためのM&A、市場での地位を固めるための医療施設との戦略的提携に注力すべきです。このように、課題は存在するもの、技術革新と市場適応を中心とした戦略的アプローチを採用することで軽減することが可能であり、CPB機器の展望の中でビジネス成長の有望な道を提供することができます。

市場力学：急速に進化する人工心肺装置市場の主要市場洞察を公開

人工心肺装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の心血管疾患の有病率の上昇
  • 低侵襲手術に対する需要の増加
  • 医療支出の増大と医療インフラ改善のための政府の取り組み
• 市場抑制要因
  • 人工心肺装置に関連する高コスト
• 市場機会
  • モニタリングと予測分析のための人工知能の統合
  • 革新的で費用対効果の高い製品を開発するための研究開発への継続的な注力
• 市場課題
  • 製品承認のための厳しい規制要件

ポーターのファイブフォース：人工心肺装置市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：人工心肺装置市場における外部からの影響の把握

外部マクロ環境要因は、人工心肺装置市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：人工心肺装置市場における競合情勢の把握

人工心肺装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：人工心肺装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、人工心肺装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：人工心肺装置市場における成功への道筋を描く

人工心肺装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界的に心血管疾患の罹患率が上昇
    • 低侵襲手術の需要増加
    • 医療費の増加と医療インフラ改善に向けた政府の取り組み
  • 抑制要因
    • 人工心肺装置に関連する高コスト
  • 機会
    • モニタリングと予測分析のための人工知能の統合
    • 革新的でコスト効率の高い製品を開発するための研究開発に継続的に注力
  • 課題
    • 製品承認のための厳格な規制要件
• 市場セグメンテーション分析
  • 製品：全体的な手順の安全性と有効性を高めるため、酸素化装置の使用が急増
  • エンドユーザー：透析センターによる人工心肺装置の使用率が高い
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 人工心肺装置市場：製品別

• イントロダクション
• 自己輸血システム
• 人工心肺装置
• 酸素供給装置

第7章 人工心肺装置市場：用途別

• イントロダクション
• 心臓血管
• 血液透析
• 呼吸器

第8章 人工心肺装置市場：エンドユーザー別

• イントロダクション
• 透析センター
• 病院
• 専門クリニック

第9章 南北アメリカの人工心肺装置市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の人工心肺装置市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの人工心肺装置市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • Inspira、心肺バイパス装置の新製品を発表
  • Inspira Technologiesは、血液を酸素で飽和させ、二酸化炭素を除去する独自の技術であるVORTX血液酸素化装置を開発
  • LivaNova、心肺バイパス手術用エッセンツ人工心肺装置で米国FDA 510（k）認可を取得
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Becton, Dickinson and Company
• Beijing ZKSK Technology Co., Ltd.
• Braile Biomedica
• Brightwake Limited
• Chalice Medical Ltd.
• Fresenius Kabi
• Getinge AB
• Global Blood Resources, LLC
• Johnson & Johnson Services, Inc.
• LivaNova PLC
• MAQUET Holding B.V. & Co. KG.
• MC3 Cardiopulmonary
• Medtronic Plc
• MicroPort Scientific Corporation
• Nipro Corporation
• Owgels Group
• Precision Medical, Inc.
• ProCell Surgical Inc.
• Senko Medical Instrument Manufacturing Co.,Ltd.
• Sorin Group
• Stryker Corporation
• Technowood Corporation
• Teleflex Incorporated
• Terumo Group
• Xenios AG
• Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

• FIGURE 1. CARDIOPULMONARY BYPASS EQUIPMENT MARKET RESEARCH PROCESS
• FIGURE 2. CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CARDIOPULMONARY BYPASS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CARDIOPULMONARY BYPASS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CARDIOPULMONARY BYPASS EQUIPMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CARDIOPULMONARY BYPASS EQUIPMENT MARKET DYNAMICS
• TABLE 7. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY AUTOTRANSFUSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HEART-LUNG MACHINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY OXYGENATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. CARDIOPULMONARY BYPASS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. CARDIOPULMONARY BYPASS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Cardiopulmonary Bypass Equipment Market was valued at USD 306.91 million in 2023, expected to reach USD 319.92 million in 2024, and is projected to grow at a CAGR of 4.38%, to USD 414.51 million by 2030.

Cardiopulmonary bypass (CPB) equipment is critical in cardiac surgeries, facilitating blood circulation and oxygenation during procedures that require heart-lung function support. This equipment is indispensable in surgeries like coronary artery bypass grafting, heart valve repair, and heart transplants. As the global prevalence of cardiovascular diseases rises due to lifestyle factors and an aging population, the demand for CPB equipment continues to increase. Hospitals, cardiac institutes, and ambulatory surgical centers form the primary end-use sectors for this market. Key growth drivers include advancements in technology such as minimally invasive surgery, improved patient safety outcomes, and the rising number of healthcare facilities in developing regions. However, market expansion is constrained by factors like high costs of equipment, stringent regulatory requirements, and the need for skilled operators. Addressing these challenges through innovative research and development can open new avenues: for instance, exploring automated or AI-integrated systems to enhance precision and reduce human error, and developing cost-efficient models suitable for emerging markets. Additionally, with the advent of telehealth and remote healthcare solutions, there could be potential in integrating CPB data into broader patient management systems for enhanced post-operative care. Opportunities also exist in enhancing customer service through training programs for technicians and surgeons on advanced equipment usage, thereby ensuring optimal service delivery. However, competition remains stiff with established players dominating the market, posing entry barriers for new entrants. Companies should focus on continuous product innovation, mergers and acquisitions for market penetration, and strategic partnerships with healthcare facilities to solidify their market position. Thus, while challenges exist, they can be mitigated by adopting a strategic approach centered on technological innovation and market adaptation, providing promising avenues for business growth within the CPB equipment landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiopulmonary Bypass Equipment Market

The Cardiopulmonary Bypass Equipment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of cardiovascular diseases globally
  • Increasing demand for minimally invasive surgical procedures
  • Growing healthcare expenditure and government initiatives to improve healthcare infrastructure
• Market Restraints
  • High cost associated with cardiopulmonary bypass equipment
• Market Opportunities
  • Integration of artificial intelligence for monitoring and predictive analysis
  • Ongoing focus on research and development to develop innovative and cost-effective products
• Market Challenges
  • Stringent regulatory requirements for product approval

Porter's Five Forces: A Strategic Tool for Navigating the Cardiopulmonary Bypass Equipment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiopulmonary Bypass Equipment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiopulmonary Bypass Equipment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiopulmonary Bypass Equipment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiopulmonary Bypass Equipment Market

A detailed market share analysis in the Cardiopulmonary Bypass Equipment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiopulmonary Bypass Equipment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiopulmonary Bypass Equipment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiopulmonary Bypass Equipment Market

A strategic analysis of the Cardiopulmonary Bypass Equipment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiopulmonary Bypass Equipment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomedica, Brightwake Limited, Chalice Medical Ltd., Fresenius Kabi, Getinge AB, Global Blood Resources, LLC, Johnson & Johnson Services, Inc., LivaNova PLC, MAQUET Holding B.V. & Co. KG., MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corporation, Nipro Corporation, Owgels Group, Precision Medical, Inc., ProCell Surgical Inc., Senko Medical Instrument Manufacturing Co.,Ltd., Sorin Group, Stryker Corporation, Technowood Corporation, Teleflex Incorporated, Terumo Group, Xenios AG, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cardiopulmonary Bypass Equipment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Autotransfusion Systems, Heart-Lung Machines, and Oxygenators.
• Based on Application, market is studied across Cardiovascular, Hemodialysis, and Respiratory.
• Based on End-User, market is studied across Dialysis Centers, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of cardiovascular diseases globally
    • 5.1.1.2. Increasing demand for minimally invasive surgical procedures
    • 5.1.1.3. Growing healthcare expenditure and government initiatives to improve healthcare infrastructure
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with cardiopulmonary bypass equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of artificial intelligence for monitoring and predictive analysis
    • 5.1.3.2. Ongoing focus on research and development to develop innovative and cost-effective products
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory requirements for product approval
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Burgeoning usage of oxygenators as it enhances overall procedure safety and effectiveness
  • 5.2.2. End-User: High usage of cardiopulmonary bypass equipment by dialysis centers
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cardiopulmonary Bypass Equipment Market, by Product

• 6.1. Introduction
• 6.2. Autotransfusion Systems
• 6.3. Heart-Lung Machines
• 6.4. Oxygenators

7. Cardiopulmonary Bypass Equipment Market, by Application

• 7.1. Introduction
• 7.2. Cardiovascular
• 7.3. Hemodialysis
• 7.4. Respiratory

8. Cardiopulmonary Bypass Equipment Market, by End-User

• 8.1. Introduction
• 8.2. Dialysis Centers
• 8.3. Hospitals
• 8.4. Specialty Clinics

9. Americas Cardiopulmonary Bypass Equipment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cardiopulmonary Bypass Equipment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cardiopulmonary Bypass Equipment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Inspira To Unveil New Line of Cardio-Pulmonary Bypass Devices
  • 12.3.2. Inspira Technologies is Developing the VORTX Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon Dioxide
  • 12.3.3. LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Becton, Dickinson and Company
• 3. Beijing ZKSK Technology Co., Ltd.
• 4. Braile Biomedica
• 5. Brightwake Limited
• 6. Chalice Medical Ltd.
• 7. Fresenius Kabi
• 8. Getinge AB
• 9. Global Blood Resources, LLC
• 10. Johnson & Johnson Services, Inc.
• 11. LivaNova PLC
• 12. MAQUET Holding B.V. & Co. KG.
• 13. MC3 Cardiopulmonary
• 14. Medtronic Plc
• 15. MicroPort Scientific Corporation
• 16. Nipro Corporation
• 17. Owgels Group
• 18. Precision Medical, Inc.
• 19. ProCell Surgical Inc.
• 20. Senko Medical Instrument Manufacturing Co.,Ltd.
• 21. Sorin Group
• 22. Stryker Corporation
• 23. Technowood Corporation
• 24. Teleflex Incorporated
• 25. Terumo Group
• 26. Xenios AG
• 27. Zimmer Biomet Holdings, Inc.